Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial

BACKGROUND: We explored the effect of discontinuing versus continuing angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) on clinical outcomes in patients with COVID-19 according to baseline disease severity. METHODS: We randomized 659 patients with a confirm...

Descripción completa

Detalles Bibliográficos
Autores principales: Macedo, Ariane Vieira Scarlatelli, de Barros e Silva, Pedro Gabriel Melo, de Paula, Thiago Ceccatto, Moll-Bernardes, Renata Junqueira, Mendonça dos Santos, Tiago, Mazza, Lilian, Feldman, Andre, Arruda, Guilherme D`Andréa Saba, de Albuquerque, Denílson Campos, de Sousa, Andrea Silvestre, de Souza, Olga Ferreira, Gibson, C. Michael, Granger, Christopher B., Alexander, John H., Lopes, Renato D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993458/
https://www.ncbi.nlm.nih.gov/pubmed/35405099
http://dx.doi.org/10.1016/j.ahj.2022.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993458/
https://www.ncbi.nlm.nih.gov/pubmed/35405099
http://dx.doi.org/10.1016/j.ahj.2022.04.001

Ejemplares similares